No Mystery The news shows that Dr Anke Schulte, an “internationally acclaimed expert in diabetes and cell therapy regenerative medicine”, has been imbedded in the company and is the advisor in the newly created Sernova Advisory Board. Subsequent words to that message from the Doctors Toleikis and Schulte indicate that they were/are in a collaboration and have been for years as they describe the relationship. To me it’s all about as subtle as a real hard kick to the huevos. I believe Dr Schulte with her resume and experience Is very capable of acting as an advisor alright. I believe she will ultimately advise the CEO of Sanofi when to put some ink to the check book.
If if they are showing USD$50B in the pockets, that would be enough to initiate an interesting starting point for an offer to purchase for the company, wouldn’t it? Doctor Witkowski must be showing some encouraging results.